ABSTRACT
This research work is on the preliminary determination of active components in bitter leaf root (vernonia amygdalina) in the treatment of diabetes. Deficiency of hormone (insulin) causes diabetes mellitus, a disease due to too much of sugar being present in the blood. This is because without insulin in the body, the result is that sugar is extracted in the urine. Consequently, fat and proteins are readily converted to carbohydrates and finally, glucose eventually. The body reserves are used up and muscular weakness set in. This research work also is to critically look at the concept of diabetes mellitus causes, symptoms, types, anatomy and physiology of the pancreas and the effect of vernonia amygdalina root on diabetes mellitus. Also to provide adequate care for diabetes mellitus patients and to alleviate complication. Finally to determine the critical effect of different extracts of vernonia amygdalina root on wistar rats and to see the frequency on the curves. Alloxan (2, 4, 5, 6-tetraoxypyrimidine; 2, 4, 5, 6-pyrimidinetetrone) is a toxic glucose analogue, which selectively destroys insulin-producing pancreatic β-cells and causes a non-insulin-dependent diabetes mellitus (NIDDM), when administered to animal species. In this study, the protective effects of bitter leaf root on glucose tolerance test and alloxan induced diabetes were evaluated. An effort was also made to investigate the acute toxicity (LD50) of the extracts and the qualitative presence of phytoconstituents in the extracts. Male wistar albino rats (weighing 100–170g) were studies for glucose tolerance test and alloxan induced diabetes. Ethanol, methanol, hexane and ethyl acetate extracts of bitter leaf root were selected for anti-diabetic activity. Blood glucose levels were estimated at different day’s intervals on the treatment with bitter leaf root extracts and glibenclamide. These levels were compared with those of the diabetic control group. Phytochemicals analysis of bitter leaf root revealed the presence of flavonoids, carbohydrates, steroids, tannins and phenolic compounds. All the extracts of bitter leaf roots exhibited significant anti-diabetic effect in both the experimental models of diabetes mellitus. The results justified the traditional use of roots in the treatment of diabetes.
TABLE OF CONTENTS
TITLE PAGE
DEDICATION ii
ACKNOWLEDGEMENT iii
ABSTRACT iv
TABLE OF CONTENTS v
CHAPTER ONE
1.0 INTRODUCTION 1
1.1 WHAT IS DIABETES MELLITUS 1
1.2 FACTORS THAT LEAD TO ALL TYPES OF DIABETES MILLITUS 1
1.3 ANATOMY AND PHYSIOLOGY OF THE PANCREAS 2
1.4 INSULIN 2
1.5 IMPACT OF DIABETES ON HUMAN HEALTH 4
1.6 THE CHRONIC IMPLICATION OF DIABETES 4
CHAPTER TWO
2.0 LITERATURE REVIEW 6
2.1 REVIEW OF RELATIVE LITERATURE 6
2.2 TYPES OF DIABETES MILLITUS 7
2.3 SYMPTOMS OF DIABETES MELLITUS 8
2.4 HOW CAN THE BURDEN OF DIABETES BE REDUCED? 8
2.5 NORMOGLYCAEMIC ANIMAL MODEL 9
2.6 ORAL GLUCOSE LOADING ANIMAL MODEL 9
2.7 CHEMICAL INDUCTION OF DIABETES MELLITUS 9
2.8 COMPOSITION OF BITTER LEAF ROOT 10
2.9 BITTER LEAF PLANT PICTURE 12
CHAPTER THREE
3.0 METHODOLOGY 13
3.1 SAMPLE COLLECTION 13
3.2 METHOD OF EXTRACTION 13
3.3 PHYTOCHEMICALS ANALYSIS OF BITTER LEAF ROOT 14
3.4 QUALITATIVE ANALYSIS OF THE PHYTOCHEMICALS OF BITTER LEAF 15
3.5 QUANTITATIVE ANALYSIS 15
3.6 PREPARATION OF GLICLIAMIDE SOLUTION 17
3.7 PREPARATION OF ALLOXAN MONOHYDRATE SOLUTION 17
3.8 PREPARATION OF THE EXTRACTS SOLUTION 17
3.9 ANIMAL STUDY 17
3.10 COLLECTION AND ACCLIMATIZATION OF RATS 18
CHAPTER FOUR
RESULTS 20
DISSCUSIONS 22
CHAPTER FIVE
CONCLUSION 24
RECOMMENDATION 25
REFERENCE 26
